Incidence of and risk factors for adverse cardiovascular events among patients with systemic lupus erythematosus
about
Stroke in systemic lupus erythematosus: a meta-analysis of population-based cohort studiesUnmet medical needs in systemic lupus erythematosusCardiovascular disease in lupus: insights and updatesExcess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls.Risk factors in the progression of subclinical atherosclerosis in women with systemic lupus erythematosus.Endothelial dysfunction in chronic inflammatory diseasesCardiovascular involvement in autoimmune diseases.Long-term cardiac changes in patients with systemic lupus erythematosusCardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions.Effect of corticosteroid use by dose on the risk of developing organ damage over time in systemic lupus erythematosus-the Hopkins Lupus CohortAtherosclerosis in systemic lupus erythematosus.Systemic lupus erythematosus and thrombosis.Bone mineral density and carotid atherosclerosis in systemic lupus erythematosus: a controlled cross-sectional study.Cardiovascular Events in Systemic Lupus Erythematosus: A Nationwide Study in Spain From the RELESSER Registry.Long-term survival and death causes of systemic lupus erythematosus in China: a systemic review of observational studiesCoronary calcification in SLE: comparison with the Multi-Ethnic Study of AtherosclerosisSemiquantified noncalcified coronary plaque in systemic lupus erythematosus.Longitudinal Evaluation of Lipoprotein Variables in Systemic Lupus Erythematosus Reveals Adverse Changes with Disease Activity and Prednisone and More Favorable Profiles with Hydroxychloroquine Therapy.Assessment of the independent associations of IgG, IgM and IgA isotypes of anticardiolipin with thrombosis in SLE.2013 update: Hopkins lupus cohort.Relationship Between Systemic Lupus Erythematosus Disease Activity Index Scores and Subclinical Cardiac Problems.Cumulative Corticosteroid Dose Over Fifty-Two Weeks in Patients With Systemic Lupus Erythematosus: Pooled Analyses From the Phase III Belimumab Trials.Altered lipoproteins in patients with systemic lupus erythematosus are associated with augmented oxidative stress: a potential role in atherosclerosis.Suboptimal inhibition of platelet cyclooxygenase 1 by aspirin in systemic lupus erythematosus: association with metabolic syndrome.Mortality and cardiovascular burden of systemic lupus erythematosus in a US population-based cohort.Atherosclerotic plaques occur in absence of intima-media thickening in both systemic sclerosis and systemic lupus erythematosus: a duplexsonography study of carotid and femoral arteries and follow-up for cardiovascular events.Death causes and pathogens analysis of systemic lupus erythematosus during the past 26 years.Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus.Cardiovascular risk factors, burden of disease and preventive strategies in patients with systemic lupus erythematosus: a literature review.The risk benefit ratio of glucocorticoids in SLE: have things changed over the past 40 years?Understanding systemic lupus erythematosus patients' desired outcomes and their perceptions of the risks and benefits of using corticosteroids.Does Renin-Angiotensin System Blockade Protect Lupus Nephritis Patients From Atherosclerotic Cardiovascular Events? A Case-Control Study.Why targeted therapies are necessary for systemic lupus erythematosus.The evolving concept of SLE comorbidities.Incidence and risk of heart failure in systemic lupus erythematosus.Progression of noncalcified and calcified coronary plaque by CT angiography in SLE.Comorbidities in Patients With Primary Sjögren's Syndrome and Systemic Lupus Erythematosus: A Comparative Registries-Based Study.Is chronic periodontitis premature in systemic lupus erythematosus patients?Low-dose aspirin as primary prophylaxis for cardiovascular events in systemic lupus erythematosus: a long-term retrospective cohort study.Subclinical left ventricular dysfunction in childhood-onset systemic lupus erythematosus: a two-dimensional speckle-tracking echocardiographic study.
P2860
Q26771476-50809338-DA64-4E9D-968A-5755E4C73116Q27005906-3C3ACFF1-FF7A-4BF6-87E4-7EF0B21DEF29Q27016554-897B80E2-E751-4430-826B-BFA1D08B3F25Q33570432-BAD58136-16F4-4914-A4EB-AE7F0BEB1DB3Q33800900-1B41F4F8-3311-4A27-B0A4-330C902A4F50Q34072179-0FBA20A2-19A2-47B9-8916-CF681F671E95Q34081242-0FAABC9D-B945-41DE-AE41-58A758F88564Q34699205-41C3B33C-47D5-4930-950E-E344C3AF108EQ35121150-14A416CF-FE09-47AD-9B07-E3BCE45122DFQ35229284-05E6F07B-8FB0-4F90-8AE3-E7668E841D2CQ35525108-D5D2DCA5-A2B7-4B3D-85D1-E54499775B9FQ35530248-456B36C0-975C-4BE3-9DD4-7D8978EEF1D0Q35530495-A8ACB528-F775-4230-885F-504CB2A4D59EQ36153524-491477B4-9D38-49DB-8B36-ADCBC1241AD5Q36153696-A0000755-4B55-429F-8ECE-BEF003920D5AQ36468887-603A502A-8B1F-477D-B6F2-764ACF8D62EFQ36709328-F141335F-D71E-49A1-9424-DC1E20373E03Q36759420-408EE4E3-DD12-4E3B-8C02-D5CD4243289EQ37063656-CB00713B-B2C4-45B1-9A84-8A73A68166DDQ37131283-2260F7C9-EF3F-47DF-B117-5311B09CDFEBQ37350506-AC1592F3-1221-4AA2-86F1-F4DEB8FFE1ADQ37456307-5820A68B-F0DA-4D59-A7CB-B9B842C9FED6Q37547130-75709482-CDC4-4AF2-B13B-438A2434FBB5Q37625058-EFEB37AC-5006-48DB-960A-1F27ED3AD50BQ37684625-72E503EE-A31A-4C45-A834-57CEC136A80CQ37690605-148D9FEE-9F7A-453A-8D20-E5178B6E8692Q38138918-3D287921-5C88-4B01-93F0-BEAB04B51EE6Q38162490-79F46712-6D37-49F8-8E97-61E7B2FE09B3Q38554636-57DE33AE-AAEA-4A33-A7C8-F9354DF4CAC3Q38608906-51C64BEB-74A8-4489-A438-9542E73EE5BFQ38635119-6B4B1701-608F-4EF5-8C50-2D17DBAC8962Q38909471-2F5B0AC7-1830-4B26-ACE6-2F3A495FB4CBQ38920435-29549A48-4A9B-4FCB-9F06-E2526CD7CEB0Q39283399-F6FEFB27-447D-4659-9F0D-071DED9E9471Q39405417-2C9D21E0-FE4B-4810-A1CA-AE4A79DCB69DQ40459284-D191B391-01DF-43A5-A7EB-2AFBAEE1EE6EQ40562190-FD090A94-1DF2-4988-A69D-0020BD9D688DQ40608767-143BCB23-6674-4CCC-A529-5E01FD5A8115Q40725518-78F35A0E-C4F3-43DE-8C45-AB0CACB64F02Q41435721-58F0D7FF-2029-401F-96D5-3F2695BFB391
P2860
Incidence of and risk factors for adverse cardiovascular events among patients with systemic lupus erythematosus
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Incidence of and risk factors ...... h systemic lupus erythematosus
@ast
Incidence of and risk factors ...... h systemic lupus erythematosus
@en
type
label
Incidence of and risk factors ...... h systemic lupus erythematosus
@ast
Incidence of and risk factors ...... h systemic lupus erythematosus
@en
prefLabel
Incidence of and risk factors ...... h systemic lupus erythematosus
@ast
Incidence of and risk factors ...... h systemic lupus erythematosus
@en
P2860
P356
P1476
Incidence of and risk factors ...... h systemic lupus erythematosus
@en
P2093
Laurence S Magder
P2860
P304
P356
10.1093/AJE/KWS130
P407
P577
2012-09-27T00:00:00Z